Chenguang Biotech Group Cash Flow Quality Index
Chenguang Biotech Group cash flow quality index. Chenguang Biotech Group (300138) has a Cash Flow Quality Index of 5.91x as of September 2025. Operating cash flow of CN¥524.96 Million exceeds net income of CN¥88.86 Million, indicating high earnings quality where cash backs reported profits. See Chenguang Biotech Group free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Chenguang Biotech Group (2007–2025)
Cash flow quality index of Chenguang Biotech Group from 2007 to 2025. Historical Cash Flow Quality Index for Chenguang Biotech Group across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Chenguang Biotech Group service its debt to assess how comfortably operating cash covers total debt obligations.
Chenguang Biotech Group Cash Flow Quality Index by Year (2007–2025)
Chenguang Biotech Group cash flow quality index by year from 2007 to 2025. Year-by-year earnings quality comparison for Chenguang Biotech Group. For the full cash flow conversion analysis, see 300138 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.58x | CN¥212.91 Million | CN¥368.87 Million | ▲ +120.2% |
| 2024 | -2.86x | CN¥-222.81 Million | CN¥77.96 Million | ▼ -168.4% |
| 2023 | -1.07x | CN¥-510.91 Million | CN¥479.72 Million | ▼ -163.2% |
| 2022 | 1.69x | CN¥734.81 Million | CN¥436.09 Million | ▲ +824.5% |
| 2021 | 0.18x | CN¥63.90 Million | CN¥350.60 Million | ▼ -90.8% |
| 2020 | 1.99x | CN¥529.41 Million | CN¥266.14 Million | ▲ +1651.2% |
| 2019 | -0.13x | CN¥-24.35 Million | CN¥189.85 Million | ▲ +67.5% |
| 2018 | -0.39x | CN¥-56.18 Million | CN¥142.43 Million | ▲ +65.2% |
| 2017 | -1.13x | CN¥-145.95 Million | CN¥128.66 Million | ▲ +64.8% |
| 2016 | -3.22x | CN¥-321.62 Million | CN¥99.89 Million | ▼ -240.4% |
| 2015 | -0.95x | CN¥-64.66 Million | CN¥68.37 Million | ▼ -107.2% |
| 2014 | 13.20x | CN¥272.96 Million | CN¥20.67 Million | ▲ +486.2% |
| 2013 | -3.42x | CN¥-36.47 Million | CN¥10.66 Million | ▼ -40.8% |
| 2012 | -2.43x | CN¥-142.11 Million | CN¥58.54 Million | ▼ -318.6% |
| 2011 | 1.11x | CN¥82.18 Million | CN¥74.00 Million | ▲ +140.2% |
| 2010 | -2.76x | CN¥-190.51 Million | CN¥68.93 Million | ▼ -670.0% |
| 2009 | 0.48x | CN¥27.23 Million | CN¥56.17 Million | ▲ +126.0% |
| 2008 | 0.21x | CN¥9.06 Million | CN¥42.25 Million | ▲ +113.2% |
| 2007 | -1.62x | CN¥-23.02 Million | CN¥14.22 Million | — |